print this page | email this page
David Calkins Promoted to Director of Research for the Vanderbilt Eye Institute
NASHVILLE, TN — Catalyst For a Cure Principal Investigator David Calkins, PhD was promoted to Director of Research for the Vanderbilt Eye Institute, effective April 1, 2009.
Dr. Calkins has a distinguished background, receiving his PhD at University of Pennsylvania and then doing his postdoctoral work at Johns Hopkins. He joined The Vanderbilt Eye Institute at Vanderbilt University Medical Center in the spring of 2004 from the University of Rochester.
Since arriving at Vanderbilt, Dr. Calkins has built a large and successful research team studying the pathogenesis of glaucoma with particular attention to neuroprotection. He has received funding from the National Eye Institute, the National Institute of Aging, and the Glaucoma Research Foundation, as well as collaborations with industrial partners. He has organized two very successful symposia on Glaucoma and Neuroprotective Strategies that have attracted clinicians and scientists from around the world.
As a principal investigator for the Catalyst For a Cure (CFC), a collaborative research initiative funded by the Glaucoma Research Foundation, Dr. Calkins and the other CFC investigators have reported and published research findings containing significant implications, whose further study may well lead to new diagnostics or treatment possibilities for glaucoma.